Grant: Catalyst Grant: Analysis of CLSA Data
McMaster University
$70,000.00
Sarcopenia and mobility impairment and the associated consequences in Canadians: an analysis of the Canadian Longitudinal Study on Aging (CLSA)
EF 2016-17
Résumé
As the life expectancies of Canadians continue to increase, there is an urgent need to identify modifiable factors that are associated with health in aging adults. Sarcopenia is the age related decrease in muscle mass and muscle strength/function. Sarcopenia is associated with increased risk of mobility impairment, functional dependence, institutionalization and mortality. Prevalence estimates of sarcopenia vary between 1% and 33% for community dwelling adults over the age of 65 years. The variability in prevalence estimates is partially attributable to the many criteria used to define sarcopenia and lack of good population based studies to estimate the burden of sarcopenia. Our project will compare the four most commonly used sarcopenia definitions to determine which definition is most strongly associated with functional limitations. Our secondary goal is to estimate the prevalence of sarcopenia for the first time in Canadians using the definition most strongly associated with functional limitations.
This project will contribute to future research efforts within and outside of the CLSA. The knowledge of a clear case definition of sarcopenia is critical to determine the temporal relationship between sarcopenia, frailty, and disability which will help determine at what point interventions and preventative measures should be taken. A clear case definition will also facilitate research exploring the role of social, demographic, and lifestyle risk factors that are associated with sarcopenia to better identify those at risk for sarcopenia and who may benefit from interventions. The CLSA is an optimal platform to conduct this research because of the breadth of variables available. In the future, the longitudinal study design which will allow for causal associations between risk factors and sarcopenia to be established.
Programme
Catalyst Grant: Analysis of CLSA Data
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
352965
Name
Phillips Stuart M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Catalyst Grant: Analysis of CLSA Data
Projecttitle
Sarcopenia and mobility impairment and the associated consequences in Canadians: an analysis of the Canadian Longitudinal Study on Aging (CLSA)
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Analysis of CLSA Data
Keyworddelim
Aging; Disability; Frailty; Functional Decline; Functional Dependence; Mobility; Sarcopenia; Skeletal Muscle
Abstract
As the life expectancies of Canadians continue to increase, there is an urgent need to identify modifiable factors that are associated with health in aging adults. Sarcopenia is the age related decrease in muscle mass and muscle strength/function. Sarcopenia is associated with increased risk of mobility impairment, functional dependence, institutionalization and mortality. Prevalence estimates of sarcopenia vary between 1% and 33% for community dwelling adults over the age of 65 years. The variability in prevalence estimates is partially attributable to the many criteria used to define sarcopenia and lack of good population based studies to estimate the burden of sarcopenia. Our project will compare the four most commonly used sarcopenia definitions to determine which definition is most strongly associated with functional limitations. Our secondary goal is to estimate the prevalence of sarcopenia for the first time in Canadians using the definition most strongly associated with functional limitations.
This project will contribute to future research efforts within and outside of the CLSA. The knowledge of a clear case definition of sarcopenia is critical to determine the temporal relationship between sarcopenia, frailty, and disability which will help determine at what point interventions and preventative measures should be taken. A clear case definition will also facilitate research exploring the role of social, demographic, and lifestyle risk factors that are associated with sarcopenia to better identify those at risk for sarcopenia and who may benefit from interventions. The CLSA is an optimal platform to conduct this research because of the breadth of variables available. In the future, the longitudinal study design which will allow for causal associations between risk factors and sarcopenia to be established.
Competitiondate
201608
Approvedterm2
1 yr 0 mth
Pinamesdelim
Phillips, Stuart M
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Genetics~ $70,000~ $0~